Post Intensive Care Unit Syndrome Clinical Trial
Official title:
Smartphone Delivery of Cognitive Behavioral Therapy for Post-intensive Care Syndrome-Family: A Pilot Study
Family members of critically ill (ICU) patients are at risk for developing significant symptoms of anxiety, depression, and post-traumatic stress during and after the ICU experience. Cognitive behavioral therapy is a form of therapy that can help individuals cope with stressful events in a more active and effective way. This study will examine the effectiveness of a smartphone self-care app delivering cognitive behavioral therapy in decreasing the psychological symptoms suffered by ICU family members. Half of the sample will receive the self-care app and half of the study sample will receive the usual supportive care given to family members of ICU patients. The researchers anticipate the self-care app will diminish the severity of anxiety, depression, and post-traumatic stress symptoms experienced by ICU family members.
Family members of critically ill patients suffer symptoms of post-intensive care
syndrome-family (PICS-F), including anxiety, depression, and post-traumatic stress disorder
with a diminished quality of life. These symptoms persist long after the episode of critical
illness and can linger for years. Cognitive behavioral therapy has become the primary
non-pharmacological treatment of an increasing list of psychological symptoms and disorders,
including anxiety, depression, and post-traumatic stress. For mild-to-moderate symptoms,
mobile technology delivery of cognitive behavioral therapy without input from a clinician has
been found to be feasible and well-accepted with efficacy that rivals face-to-face therapy.
The purpose of this pilot study is to examine the efficacy of smartphone delivery of
cognitive behavioral therapy via a mobile health app (intervention) on the severity and
prevalence of PICS-F symptoms in family members of critically ill patients. The study will
include family members of critically ill patients admitted to two 26-bed ICUs at the Akron
campus of Summa Health System. A prospective, repeated measures, longitudinal design with
randomization to two groups (control, intervention) will be employed. Primary outcome
measures will include symptoms of PICS-F (anxiety, depression, post-traumatic stress),
health-related quality of life, and mental health self-efficacy measured at enrollment, 30
days after enrollment, and 60 days after enrollment. App usage over the course of the study
(number of logins, total time spent with app) will be obtained at the final time point of the
study (60 days after enrollment). A sample size of 60 family members is planned for this
pilot study (30 intervention, 30 control). The sample size was determined according to the
recommendations of Whitehead et al.estimating an a priori small effect size and an attrition
rate of 30% derived from previous studies.
The aims of the study are:
Aim 1: Determine the prevalence and severity of PICS-F symptoms (anxiety, depression,
post-traumatic stress), health-related quality of life (HRQOL), and mental health
self-efficacy (MHSE) in family decision makers of critically ill patients and their change
over time (enrollment, 30 days, 60 days).
Aim 2: Determine differences in PICS-F symptom severity, HRQOL, and MHSE in family decision
makers of critically ill patients receiving a mobile health app (MHapp) intervention compared
to family members receiving standard care and support.
Aim 3: Determine the relationship between the dose of the MHapp (total time spent with the
app, total log-ins) over the course of the study (60 days) and changes in PICS-F symptom
severity (anxiety, depression, post-traumatic stress), HRQOL, and MHSE.
Data Analysis and Statistical Plan: Data will be analyzed using Statistics Package for the
Social Sciences (SPSS, Version 25) software. Descriptive statistics will be used to assess
frequencies and variability of the data, coding inaccuracies, outliers, and missing data. The
statistical plan for each specific aim is as follows:
Aim 1: The investigators will report study variables with descriptive statistics. Change over
time will be examined with repeated measures ANOVA.
Aim 2: Differences between intervention and control groups will be assessed with student's
t-test. Differences between groups in regard to severity of PICS-F symptoms will be used to
calculate effect size for the intervention.
Aim 3: Relationship between total MHapp dose and longitudinal change in study variables will
be examined with Pearson's correlation.
Human Subjects and Ethical Issues: The research presents no more than minimal psychological
risk or harm, largely from the possibility that answering the questions on the anxiety,
depression, and stress instruments may be distressing for participants. Psychological risk
will be minimized by emphasizing that study participants can stop participating in the study
at any time and are not obligated to answer any question that they find distressing. Family
members who endorse clinically significant symptoms will be referred to their primary care
physician. Family members of patients who die during the study will be referred to local
bereavement support groups.
There is a low risk of privacy or confidentiality loss. Risk will be minimized by the
following measures: (a) the only record linking the participant and the research data is the
consent document; (b) consent documents will be kept in a locked cabinet in the locked office
of the PI; (c) data will be entered and stored by the RA on REDCap, a secure, HIPAA-compliant
web-based platform; (d) all data files obtained for analysis will be stored on a
password-protected laptop computer stored in a locked room; and (e) The PI, co-investigators,
and research assistant (RA) are the only individuals with access to the data files.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
| Completed |
NCT04501445 -
Psychological Symptoms and Families of COVID-19 Patients
|
N/A | |
| Recruiting |
NCT05182086 -
Improving Recovery After Critical Illness
|
N/A | |
| Recruiting |
NCT05537298 -
Muscle Recovery After Critical Illness
|
||
| Completed |
NCT04194229 -
Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors
|
||
| Active, not recruiting |
NCT06119711 -
Micronutrient Levels and Nutritional Status in Critical Illness
|
||
| Completed |
NCT04154995 -
Intensive Care Unit Recovery
|
||
| Completed |
NCT04412330 -
Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19
|
N/A | |
| Completed |
NCT04476914 -
Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU
|
||
| Recruiting |
NCT04608994 -
Long-term Follow up in Survivors of Critical Illness
|
||
| Completed |
NCT04422444 -
Post Intensive Care Syndrome in COVID19 Patients
|
||
| Completed |
NCT05537311 -
Reducing Isolation and Feeling of Loneliness During Critical Illness
|
N/A | |
| Recruiting |
NCT04967365 -
Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study
|
||
| Recruiting |
NCT04163497 -
ICU Diaries and Its Effects After the Unit Discharge
|
N/A | |
| Active, not recruiting |
NCT04317144 -
Web-based Follow-up to Former ICU Patients
|
N/A | |
| Recruiting |
NCT06019078 -
pEEG Monitoring Effect on Delirium, Ventilator Days, and PICS
|
||
| Terminated |
NCT04175717 -
Feasibility of a Physiotherapy-led Follow-up Programme in Adult Critical Illness Survivors
|
N/A | |
| Active, not recruiting |
NCT04637113 -
Singapore's Health Outcomes After Critical Illness in Kids
|
||
| Active, not recruiting |
NCT04099472 -
Partnering With Family Members to Prevent, Detect and Manage Delirium in Critically Ill Patients.
|
N/A | |
| Completed |
NCT04940208 -
Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit
|